| Product Code: ETC10815330 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Finland`s small molecule CDMO import market continued to show steady growth with a CAGR of 1.3% from 2020 to 2024. The top exporting countries to Finland were the USA, Latvia, Metropolitan France, China, and Sweden. Despite a high growth rate of 74.32% from 2023 to 2024, the market concentration, as measured by the HHI, remained at a moderate level. This indicates a competitive landscape in the Finnish small molecule CDMO import market, with diverse sources for these services contributing to its growth.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Small Molecule CDMO Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Small Molecule CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Small Molecule CDMO Market - Industry Life Cycle |
3.4 Finland Small Molecule CDMO Market - Porter's Five Forces |
3.5 Finland Small Molecule CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Finland Small Molecule CDMO Market Revenues & Volume Share, By API Type, 2021 & 2031F |
3.7 Finland Small Molecule CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.8 Finland Small Molecule CDMO Market Revenues & Volume Share, By Facility Type, 2021 & 2031F |
3.9 Finland Small Molecule CDMO Market Revenues & Volume Share, By Regulatory Compliance, 2021 & 2031F |
4 Finland Small Molecule CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for outsourcing services in pharmaceutical manufacturing industry |
4.2.2 Growing focus on research and development activities in the biopharmaceutical sector |
4.2.3 Favorable government policies supporting the growth of contract development and manufacturing organizations (CDMOs) |
4.3 Market Restraints |
4.3.1 Intense competition from established CDMOs in other regions |
4.3.2 Regulatory challenges and compliance requirements impacting operations and timelines |
5 Finland Small Molecule CDMO Market Trends |
6 Finland Small Molecule CDMO Market, By Types |
6.1 Finland Small Molecule CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Small Molecule CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Finland Small Molecule CDMO Market Revenues & Volume, By Drug Substance Development, 2021 - 2031F |
6.1.4 Finland Small Molecule CDMO Market Revenues & Volume, By Drug Product Manufacturing, 2021 - 2031F |
6.1.5 Finland Small Molecule CDMO Market Revenues & Volume, By Formulation Services, 2021 - 2031F |
6.1.6 Finland Small Molecule CDMO Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.7 Finland Small Molecule CDMO Market Revenues & Volume, By Packaging & Logistics, 2021 - 2031F |
6.2 Finland Small Molecule CDMO Market, By API Type |
6.2.1 Overview and Analysis |
6.2.2 Finland Small Molecule CDMO Market Revenues & Volume, By Generic APIs, 2021 - 2031F |
6.2.3 Finland Small Molecule CDMO Market Revenues & Volume, By Specialty APIs, 2021 - 2031F |
6.2.4 Finland Small Molecule CDMO Market Revenues & Volume, By Biotech APIs, 2021 - 2031F |
6.2.5 Finland Small Molecule CDMO Market Revenues & Volume, By Oncology Drug APIs, 2021 - 2031F |
6.2.6 Finland Small Molecule CDMO Market Revenues & Volume, By High-Potency APIs, 2021 - 2031F |
6.3 Finland Small Molecule CDMO Market, By Drug Development Stage |
6.3.1 Overview and Analysis |
6.3.2 Finland Small Molecule CDMO Market Revenues & Volume, By Early-Stage Discovery, 2021 - 2031F |
6.3.3 Finland Small Molecule CDMO Market Revenues & Volume, By Preclinical Trials, 2021 - 2031F |
6.3.4 Finland Small Molecule CDMO Market Revenues & Volume, By Clinical Trials Phase 1, 2021 - 2031F |
6.3.5 Finland Small Molecule CDMO Market Revenues & Volume, By Commercial Manufacturing, 2021 - 2031F |
6.3.6 Finland Small Molecule CDMO Market Revenues & Volume, By Post- Surveillance, 2021 - 2031F |
6.4 Finland Small Molecule CDMO Market, By Facility Type |
6.4.1 Overview and Analysis |
6.4.2 Finland Small Molecule CDMO Market Revenues & Volume, By Pilot Scale, 2021 - 2031F |
6.4.3 Finland Small Molecule CDMO Market Revenues & Volume, By Large-Scale Production, 2021 - 2031F |
6.4.4 Finland Small Molecule CDMO Market Revenues & Volume, By R&D Facilities, 2021 - 2031F |
6.4.5 Finland Small Molecule CDMO Market Revenues & Volume, By Sterile Manufacturing Units, 2021 - 2031F |
6.4.6 Finland Small Molecule CDMO Market Revenues & Volume, By Integrated Supply Chain Management, 2021 - 2031F |
6.5 Finland Small Molecule CDMO Market, By Regulatory Compliance |
6.5.1 Overview and Analysis |
6.5.2 Finland Small Molecule CDMO Market Revenues & Volume, By US FDA & EMA Approved, 2021 - 2031F |
6.5.3 Finland Small Molecule CDMO Market Revenues & Volume, By GMP & ISO 13485 Certified, 2021 - 2031F |
6.5.4 Finland Small Molecule CDMO Market Revenues & Volume, By WHO GMP Standards, 2021 - 2031F |
6.5.5 Finland Small Molecule CDMO Market Revenues & Volume, By Good Laboratory Practices, 2021 - 2031F |
6.5.6 Finland Small Molecule CDMO Market Revenues & Volume, By Hazardous Material Handling, 2021 - 2031F |
7 Finland Small Molecule CDMO Market Import-Export Trade Statistics |
7.1 Finland Small Molecule CDMO Market Export to Major Countries |
7.2 Finland Small Molecule CDMO Market Imports from Major Countries |
8 Finland Small Molecule CDMO Market Key Performance Indicators |
8.1 Average project turnaround time |
8.2 Percentage of projects with successful regulatory approvals |
8.3 Client satisfaction score based on project delivery and quality |
8.4 Percentage of repeat business from existing clients |
8.5 Number of new client acquisitions within a specific time period |
9 Finland Small Molecule CDMO Market - Opportunity Assessment |
9.1 Finland Small Molecule CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Finland Small Molecule CDMO Market Opportunity Assessment, By API Type, 2021 & 2031F |
9.3 Finland Small Molecule CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
9.4 Finland Small Molecule CDMO Market Opportunity Assessment, By Facility Type, 2021 & 2031F |
9.5 Finland Small Molecule CDMO Market Opportunity Assessment, By Regulatory Compliance, 2021 & 2031F |
10 Finland Small Molecule CDMO Market - Competitive Landscape |
10.1 Finland Small Molecule CDMO Market Revenue Share, By Companies, 2024 |
10.2 Finland Small Molecule CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here